. Author manuscript; available in PMC: 2009 Apr 16.

Published in final edited form as: Otol Neurotol. 2008 Feb;29(2):149–155. doi: 10.1097/mao.0b013e31812f7244

TABLE 1.

Biographical information for the CI users who participated in the studies

L	Age^a	Dur deaf^a	CI exp^a	Cause	Device	Processor	Strategy
L1	27	13	6	Unknown	C1	Platinum BTE	CIS
L2	61	1.5	1	Unknown	CI24R(CS)	ESPrit 3G	ACE
L3	69	22	6	Idiopathic	CI24M	ESPrit 3G	ACE
L4	61	2	2	Infection	CI24R(CS)	Sprint	ACE
L5	41	0.5	0.5	Trauma	HiRes 90K	Auria	HiRes-P
L6	76	40	0.5	Otosclerosis	HiRes 90K	Auria	HiRes-P
L7	41	41	5	Congenital	CII	Harmony	HiRes/HiRes 120
L8	49	Unknown	2	Congenital	Combi40+	Tempo+	CIS

In years. L, listener; Dur deaf, duration of deafness; CI exp, duration of CI experience; C1, Clarion C1; CI24R, Nucleus CI24R; CI24M, Nucleus CI24M; CI24R (CS), Nucleus CI24R (CS); HiRes 90K, Advanced Bionics HiRes 90K; CII, Clarion CII; Combi 40+, Med-El Combi 40+; BTE, behind the ear; CIS, continuous interleaved sampling; ACE, advanced combinational encoder.